Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

809 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-01

Study Completion Date

2020-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants are healthcare workers and adult outpatients referred in a COVID-19 screening center. Patients-reported symptoms are collected, then participants underwent a simple olfactory test (CODA for Clinical Olfactory Dysfunction Assessment), prior to swabbing for SARS-CoV-2 diagnosis (RT-PCR). We aimed to evaluate the prevalence of smell and taste disorders, and to calculate the diagnostic value of patient-reported and clinically verified smell disorders in persons with suspected COVID-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients

NCT04526054

Olfaction Disorders COVID-19

COMPLETED NA

ScentAware and OCT in MCI vs HC

NCT06377241

Alzheimer Disease, Early Onset

TERMINATED

Eye Detection to Identify Novel Coronavirus Infection

NCT04907981

Covid19

COMPLETED

Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic

NCT04387292

COVID19 Ophthalmopathy

COMPLETED NA

Corneal Topographic Changes in Different Grades of OSA

NCT06347900

Corneal Ectasia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-19

Healthcare workers and adult outpatients attending the COVID-19 screening center of the University Hospital of Montpellier, France.

Reporting of anosmia, ageusia and other clinical symptoms

Intervention Type BIOLOGICAL

Reporting of anosmia, ageusia and other clinical symptoms related to COVID-19 - CODA test - SARS-CoV2 RT-PCR and ELISA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reporting of anosmia, ageusia and other clinical symptoms

Reporting of anosmia, ageusia and other clinical symptoms related to COVID-19 - CODA test - SARS-CoV2 RT-PCR and ELISA

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symptoms compatible with COVID-19
* Close exposure to a confirmed COVID-19 index case
* Ambulatory (asymptomatic, or if symptomatic, did not require hospitalisation, thus with initial mild disease)

Exclusion Criteria

* known history of smell and taste disorders
* testing inability (cognitive impairment, non native French speakers, test malingering)
* testing contraindication (children, pregnancy, breastfeeding, specific allergies).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes